Mission
OPERATE A STATE-OF-THE-ART, WORLD-CLASS GENOMIC RESEARCH CENTER THAT CREATES AND USES ADVANCED GENOMICS TO UNDERSTAND THE GENETIC BASIS OF DISEASE. FOR MORE INFORMATION, SEE SCHEDULE O.
Public Charity
NEW YORK GENOME CENTER INC
NEW YORK GENOME CENTER INC, of NEW YORK, NY, is a Public Charity tracked in Imperigo's IRS 990 database. The 2024 filing shows $82.3M in revenue, $84.3M in expenses, $167.0M in total assets. 83 publicly reported grants to this organization, totaling roughly $52.3M, appear in IRS filings.
EIN: 800631734
NEW YORK, NY
General Hospitals
NTEE: E22
Latest filing: 2024
Total Revenue$82.3M
Total Expenses$84.3M
Total Assets$167.0M
Grant Records83
Funding Total$52.3M
Filing Years2019–2024
Where $100 goes at New York Genome Center Inc
How New York Genome Center Inc divides every $100 it spends, from its own Form 990 filings, averaged across 7 years.
$79
Programs
the work itself
$20
Management
running the organization
$1
Fundraising
raising the next dollar
Inside the $79 for programs
$70
Genome sequencing
$9
Clinical sequencing
Source: Form 990 filings with the IRS, latest fiscal year 2024. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
CROSS-SPECIES ANALYSIS OF MICROGLIAL STATES IN HETEROGENEOUS ALZHEIMER'S DISEASE PROGRESSION
$86,250
$3,175,195
IN FURTHERANCE OF GRANTEE'S TAX-EXEMPT PURPOSE
$2,100,000
HEALTH
$1,505,000
Research
$1,415,307
Showing up to 5 of 83 total records — full history available with membership.
Officers & Directors
DIRECTOR (STARTED 6/24)
Alondra Nelson Phd
DIRECTOR
Anthony B Evnin Phd
DIRECTOR, CLINICAL BIOINFORM.
Avinash Vijay Abhyankar
DIRECTOR (STARTED 10/24)
Barbara Rosati Phd
DIRECTOR
Bruce Stillman Phd
CHIEF BUSINESS OFFICER
Carol Ashe
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $82.3M | $84.3M | $167.0M |
| 2023 | $92.9M | $81.9M | $184.1M |
| 2022 | $67.9M | $72.2M | $181.7M |
| 2020 | $60.8M | $72.3M | $83.5M |
| 2019 | $42.2M | $80.2M | $97.1M |
Between 2019 and 2024, reported annual revenue grew from $42.2M to $82.3M (+95%), with total assets most recently reported at $167.0M.
Interactive year-over-year charts and full filing details available with membership.